Cutanogen Corp., Cambrex deal

CBM acquired Cutanogen for $1.5 million in cash. Cutanogen shareholders also are eligible for up to $4.8 million in milestones. Cutanogen's lead product, PermaDerm cultured skin, received Humanitaria...